alexa Masayoshi Yamaguchi | Emory University
ISSN: 2161-0509

Journal of Nutritional Disorders & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Masayoshi Yamaguchi

Masayoshi Yamaguchi Executive Editor
Masayoshi Yamaguchi
Department of Hematology and Biomedical Oncology
Emory University

Masayoshi Yamaguchi, Ph.D., IOM, FAOE, DDG, DG, is Visiting Professor in Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Baylor College of Medicine, Houston, TX, USA (2012–), Visiting Professor in Department of Pathobiology, College of Veterinary Medicine, The University of Missouri-Columbia, MO, USA (2012), Visiting Professor in Department of Foods and Nutrition, The University of Georgia, GA, USA (2011 – 2012), Visiting Professor in Division of Endocrinology and Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, GA, USA (2007 – 2011), Professor in Laboratory of Endocrinology and Molecular Metabolism, Graduate School of Nutritional Sciences, University of Shizuoka, Japan (1993 ~ August 2007), Associate Professor in Graduate School of Nutritional Sciences, University of Shizuoka, Japan (1991~1993), Assistant Professor in School of Pharmaceutical Sciences, University of Shizuoka, Japan (1987~1991), Visiting Assistant Professor in The University of Texas Medical School at Huston, USA (1988), Assistant Professor in Shizuoka College of Pharmacy, Japan (1986~1987); Visiting Assistant Professor in Texas Tech University School of Medicine, USA (1985); Visiting Lecturer in The University of Pennsylvania School of Medicine, USA (1981), Research Associate in Shizuoka College of Pharmacy, Japan (1973 ~ 1986). He received a Ph.D. in Pharmaceutical Sciences from Shizuoka College of Pharmacy (1976, Japan). He has completed his B.S. in Pharmaceutical Sciences, Shizuoka, Japan (1971).

Dr. Yamaguchi is engaged in the fields of bone and calcium endocrinology and cell calcium signaling since 1971, and these researches are developed in the aspect of biochemistry, molecular biology, endocrinology, metabolism, nutrition, pharmacology, and toxicology. Dr. Yamaguchi has an interesting for cell signaling mechanism, bone biology, nutritional factor and osteoporosis prevention, diabetic osteoporosis, and cancer bone metastasis and osteolysis. Moreover, Dr. Yamaguchi discovered two novel proteins and genes; cell signaling suppressor protein (named regucalcin; 1978) and transcriptional factor RGPR-p117 (regucalcin gene promoter region-related protein; 2001) in mammalian cells. Dr. Yamaguchi generated regucalcin transgenic rats, which were registered as international patents (USA, EU, Japan, and Korea), and this animal is found to induce osteoporosis and hyperlipidemia. The research of regucalcin is focused as a scientific topic. Dr. Yamaguchi published over 500 English articles to professional journals with peer-review. In addition, Dr. Yamaguchi registered over 20 national and international patents in the fields of his research interesting.

Dr. Yamaguchi is serving as editors and editorial board members of reputed 24 international Journals. He received many honor and awards; Prize for Sato Memorial Fundation (1992, Japan/USA), Senji Miyata Foundation Award 2005 (Japan), Japan Society for Biomedical Research on Trace Elements Award 2007, The Lifetime Achievement Award from International Biographical Centre (IBC) (2004, England), The World Lifetime Achievement Award from American Biographical Institute (2004, USA), The Distinguished Service to Science Award from IBC (2007, England), and many others. Dr. Yamaguchi is listed in various biographies; Who’s Who in the World (2005-, Marquis Who’s Who, USA), Who’s Who in Sciences and Engineering (2004-, Marquis Who’s Who, USA), International Biographical Dictionary (2006-, IBC, England), and others.

Research Interest

Bone and calcium endocrinology, endocrinology, biochemistry, nutrition, pharmacology and toxicology, the research of bone biology and osteoporosis prevention by nutritional factors in Emory University School of Medicine.


Global Speakers in the subject

Global Experts in the subject


The Regucalcin Gene is a Key in the Therapy of Hepatocellular Carcinoma
Masayoshi Yamaguchi
Editorial: J Cancer Sci Ther/Vol.6.3 e132 (2014)
DOI: 10.4172/1948-5956.1000e132
New Aspects in Obesity and Diabetes: Involvement in Regucalcin, a Suppressor Protein of Cell Signaling
Masayoshi Yamaguchi
Editorial: J Mol Genet Med 2014, S1: 010
DOI: 10.4172/1747-0862.S1-010
New Development in Osteoporosis Treatment: The Synergistical Osteogenic Effects with Vitamin D3, Menaquinone-7, Genistein and Zinc
Masayoshi Yamaguchi
Special Issue Article: Vitam Miner
DOI: 10.4172/2376-1318.S6-e001
Calcium Regulatory Protein, Regucalcin, may be a Key Molecule in Brain Disease
Masayoshi Yamaguchi
Editorial: J Mol Genet Med 2013, 7:87
DOI: 10.4172/1747-0862.1000087
Novel Protein RGPR-p117: New Aspects in Cell Regulation
Masayoshi Yamaguchi
Mini Review: J Mol Genet Med 2013, 7:72
DOI: 10.4172/1747-0862.1000072
Osteoporosis Treatment with New Osteogenic Factors, Osteoporosis
Masayoshi Yamaguchi
Review Article: J Mol Genet Med 2013, 7:66
DOI: 10.4172/1747-0862.1000066
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version